资讯

Atlantic Union Bankshares: Looking Cheap After The Sandy Spring Deal
Atlantic Union Bankshares lags behind peers in 2023 but boasts strong credit quality and trades at a low 8.5x 2026 EPS. Read ...
Aldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber Data
Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...